Special Investigation in Patients With Rheumatoid Arthritis (Working Productivity Activity Impairment)

Study Identifier
P12-772
CT.gov Identifier
NCT01346488
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Results Available

Scientific Result Summary
Available Language(s): English
Download document(s)

Study Details

Medical Condition
  • Rheumatoid Arthritis
    • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    15 - 87 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    RA patients treated with adalimumab who satisfied the following conditions: 1. Paid worker (PW) RA patients who are engaged in paid work for more than 35 hours per week 2. Home worker (HW) * Category 1 unpaid workers; RA patients who are engaged in paid work for less than 35 hours per week * Category 2 unpaid workers; RA patients who perform basic activities of daily life (household duties, shopping, child caring, exercise, study, etc.) other than PW
    Exclusion Criteria:
    1. RA patients showing lowered basic activities of daily life, such as hospitalization and being bedridden 2. RA patients with a history of previous treatment with adalimumab

    Protocol Summary

    This is a single-arm, multi-center, prospective cohort study (post-marketing observational study). The observation period for each participant is 48 weeks.

    This study is designed to provide additional data on treatment effects of adalimumab during 48 weeks of treatment in patients with RA under conditions of routine rheumatology care. Course of work productivity and work ability, the course of health-related quality of life, and changes in functionality during 48 weeks treatment with adalimumab are to be documented.

    Study Locations

    No locations found.